newsfilter
← Latest News
GlobeNewswire·

BIODESIX, INC. INVESTIGATION: BDSX Securities Investors Encouraged to Contact Kirby McInerney LLP About Their Rights

  • Kirby McInerney LLP is investigating potential claims against Biodesix, Inc. regarding possible violations of federal securities laws.
  • Biodesix reported third quarter 2026 revenue of $24.0 million, which fell below analyst expectations.
  • The company reduced its full-year 2026 revenue guidance to $101 million to $103 million from the prior range of $108 million to $114 million.
  • CEO Scott Hutton cited execution challenges, including fewer sales representatives than planned, unexpected seasonality, & customer delays as causes for the results.
  • The company averaged 101 sales representatives during the quarter due to higher turnover & a hiring pace that lagged behind attrition.
  • Biodesix shares declined by $11.31 per share, or approximately 57%, closing at $8.53 on November 6, 2026.
  • No lawsuit has been filed yet as the investigation remains ongoing to determine if claims can be brought under federal securities laws.
  • Investors may contact Lauren Molinaro at Kirby McInerney LLP via email at investigations@kmllp.com to discuss their rights.